The Lancet Psychiatry· 2026Q1
The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blinded, parallel-group, randomised controlled trial
- 1citations
- Q1SCImago
- 2026year
Short summary
Modified Psychodynamic Psychotherapy for Schizophrenia (MPP-S) plus treatment as usual (TAU) improved psychosocial functioning by -3.45 points at 24 months and -4.07 points at 36 months compared to TAU alone in a randomized controlled trial (n=130).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Psychiatry and Mental health
Psychiatry and Mental healthMedicine